These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 35927637)

  • 1. Alterations of liver enzymes and lipid profile in response to exhaustive eccentric exercise: vitamin D supplementation trial in overweight females with non-alcoholic fatty liver disease.
    Rahimpour Z; Hoseini R; Behpour N
    BMC Gastroenterol; 2022 Aug; 22(1):372. PubMed ID: 35927637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Short-term Vitamin D Supplementation on the Alterations of Glycemic Variables in Response to Exhaustive Eccentric Exercise in Patients with Non-alcoholic Fatty Liver.
    Rahimpour Z; Hoseini R; Behpour N
    Middle East J Dig Dis; 2022 Apr; 14(2):229-234. PubMed ID: 36619147
    [No Abstract]   [Full Text] [Related]  

  • 3. The short-term effect of vitamin D supplementation on the response to muscle and liver damages indices by exhaustive aerobic exercise in untrained men: a quasi-experimental study.
    Mastali VP; Hoseini R; Azizi M
    BMC Sports Sci Med Rehabil; 2022 Jan; 14(1):7. PubMed ID: 35012626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased inflammatory gene expression accompanies the improvement of liver enzyme and lipid profile following aerobic training and vitamin D supplementation in T2DM patients.
    Hoseini R; Rahim HA; Ahmed JK
    BMC Endocr Disord; 2022 Oct; 22(1):245. PubMed ID: 36209084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does naringenin supplementation improve lipid profile, severity of hepatic steatosis and probability of liver fibrosis in overweight/obese patients with NAFLD? A randomised, double-blind, placebo-controlled, clinical trial.
    Namkhah Z; Naeini F; Mahdi Rezayat S; Mehdi Yaseri ; Mansouri S; Javad Hosseinzadeh-Attar M
    Int J Clin Pract; 2021 Nov; 75(11):e14852. PubMed ID: 34516703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between 25-hydroxyvitamin D concentration and liver enzymes in overweight or obese adults: Cross-sectional and interventional outcomes.
    Naderpoor N; Mousa A; de Courten M; Scragg R; de Courten B
    J Steroid Biochem Mol Biol; 2018 Mar; 177():193-199. PubMed ID: 28899715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of short-term vitamin D on the antioxidant capacity following exhaustive aerobic exercise.
    Mastali VP; Hoseini R; Azizi M
    Afr Health Sci; 2023 Mar; 23(1):584-591. PubMed ID: 37545926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Independent and Combined Effects of Calcium and Vitamin D Supplementation on Blood Lipids in Overweight or Obese Premenopausal Women: A Triple-Blind Randomized Controlled Clinical Trial.
    Rajaie H; Rabiee MR; Bellissimo N; Faghih S
    Int J Prev Med; 2021; 12():52. PubMed ID: 34447494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of vitamin D supplementation on liver fibrogenic factors in non-alcoholic fatty liver patients with steatohepatitis: study protocol for a randomized clinical trial.
    Ebrahimpour-Koujan S; Sohrabpour AA; Foroughi F; Alvandi E; Esmaillzadeh A
    Trials; 2019 Mar; 20(1):153. PubMed ID: 30832722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Vitamin D Supplementation on Weight Loss, Glycemic Indices, and Lipid Profile in Obese and Overweight Women: A Clinical Trial Study.
    Khosravi ZS; Kafeshani M; Tavasoli P; Zadeh AH; Entezari MH
    Int J Prev Med; 2018; 9():63. PubMed ID: 30123437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of grape seed extract supplementation on cardiovascular risk factors, liver enzymes and hepatic steatosis in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study.
    Ghanbari P; Raiesi D; Alboebadi R; Zarejavid A; Dianati M; Razmi H; Bazyar H
    BMC Complement Med Ther; 2024 May; 24(1):192. PubMed ID: 38755622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Green cardamom supplementation improves serum irisin, glucose indices, and lipid profiles in overweight or obese non-alcoholic fatty liver disease patients: a double-blind randomized placebo-controlled clinical trial.
    Daneshi-Maskooni M; Keshavarz SA; Qorbani M; Mansouri S; Alavian SM; Badri-Fariman M; Jazayeri-Tehrani SA; Sotoudeh G
    BMC Complement Altern Med; 2019 Mar; 19(1):59. PubMed ID: 30871514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D and nonalcoholic fatty liver disease in children: a randomized controlled clinical trial.
    El Amrousy D; Abdelhai D; Shawky D
    Eur J Pediatr; 2022 Feb; 181(2):579-586. PubMed ID: 34459959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of vitamin D supplementation on child and adolescent overweight/obesity: a systematic review and meta-analysis of randomized controlled trials.
    Gou H; Wang Y; Liu Y; Peng C; He W; Sun X
    Eur J Pediatr; 2023 Jan; 182(1):255-264. PubMed ID: 36305951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of aerobic training and vitamin D supplementation on glycemic indices and adipose tissue gene expression in type 2 diabetic rats.
    Khaledi K; Hoseini R; Gharzi A
    Sci Rep; 2023 Jun; 13(1):10218. PubMed ID: 37353689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial.
    Jazayeri-Tehrani SA; Rezayat SM; Mansouri S; Qorbani M; Alavian SM; Daneshi-Maskooni M; Hosseinzadeh-Attar MJ
    Nutr Metab (Lond); 2019; 16():8. PubMed ID: 30705687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propolis supplementation in obese patients with non-alcoholic fatty liver disease: effects on glucose homeostasis, lipid profile, liver function, anthropometric indices and meta-inflammation.
    Nikbaf-Shandiz M; Tutunchi H; Khoshbaten M; Nazari Bonab H; Ebrahimi-Mameghani M
    Food Funct; 2022 Nov; 13(22):11568-11578. PubMed ID: 36263703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regression of Non-Alcoholic Fatty Liver by Vitamin D Supplement: A Double-Blind Randomized Controlled Clinical Trial.
    Lorvand Amiri H; Agah S; Mousavi SN; Hosseini AF; Shidfar F
    Arch Iran Med; 2016 Sep; 19(9):631-8. PubMed ID: 27631178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of naringenin supplementation in overweight/obese patients with non-alcoholic fatty liver disease: study protocol for a randomized double-blind clinical trial.
    Naeini F; Namkhah Z; Tutunchi H; Rezayat SM; Mansouri S; Jazayeri-Tehrani SA; Yaseri M; Hosseinzadeh-Attar MJ
    Trials; 2021 Nov; 22(1):801. PubMed ID: 34774104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of vitamin D supplementation on various parameters in non-alcoholic fatty liver disease patients.
    Hussain M; Iqbal J; Malik SA; Waheed A; Shabnum S; Akhtar L; Saeed H
    Pak J Pharm Sci; 2019 May; 32(3 Special):1343-1348. PubMed ID: 31551213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.